Veronesi, U., P. Maisonneuve, N. Rotmensz, B. Bonanni, P. Boyle, G. Viale, A. Costa, V. Sacchini, R. Travaglini, G. D’Aiuto, P. Oliviero, F. Lovison, G. Gucciardo, M. R. del Turco, M. G. Muraca, M. A. Pizzichetta, S. Conforti, and A. Decensi. 2007. Tamoxifen for the prevention of breast cancer: Late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy. Journal of the National Cancer Institute 99(9):727–737.

Viswanath, K., and J. Finnegan. 1996. The knowledge gap hypothesis: Twenty five years later. In Communication Yearbook. Volume 19, edited by B. R. Burleson and A. W. Kunkel. Thousand Oaks, CA: Sage Publications. Pp. 187–227.

———. 2002. Community health campaigns and secular trends: insights from the Minnesota Heart Health Program and community trials in heart disease prevention. In Public Health Communication: Evidence for Behavior Change, edited by R. C. Hornik. Mahwah, NJ: L. Erlbaum Associates. Pp. 289–312.

Watkins, C., L. Moore, I. Harvey, P. Carthy, E. Robinson, and R. Brawn. 2003. Characteristics of general practitioners who frequently see drug industry representatives: National Cross Sectional Study. British Medical Journal 326(7400):1178–1179.

Wegienka, G., S. Havstad, and J. L. Kelsey. 2006. Menopausal hormone therapy in a health maintenance organization before and after Women’s Health Initiative hormone trials termination. Journal of Women’s Health 15(4):369–378.

Weisman, C. S. 2000. Advocating for gender-specific health care: A historical perspective. Journal of Gender-Specific Medicine3(3):22–24.

Williams, R. S., D. Christie, and C. Sistrom. 2005. Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in primary care physicians. American Journal of Obstetrics and Gynecology 193(2):551–556; discussion 556–558.

Woolf, S. H. 2010. The 2009 breast cancer screening recommendations of the US Preventive Services Task Force. Journal of the American Medical Association 303(2):162–163.

Writing Group for the Women’s Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. Journal of the American Medical Association 288(3):321–333.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement